Pediatric heart transplantation

Current Opinion in Pediatrics

Volumn 14, Issue 5, 2002, Pages 611-619

  Boucek Jr , Robert J ^a   Boucek, Mark M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

AGE; CHILDHOOD MORTALITY; CONGENITAL HEART DISEASE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE IRRADIATION; LYMPHOCYTE PROLIFERATION; PLASMAPHERESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TREATMENT INDICATION;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFANT; SURVIVAL RATE;

EID: 0036785469     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200210000-00009     Document Type: Review

References (63)

1. Heart transplantation in children: Indications
2. The Registry of the International Society for Heart Lung Transplantation: Fourth Official Pediatric Report-2000
3. Method of heart transplantation for treatment of hypoplastic left heart syndrome
4. Stenting of the arterial duct and banding of the pulmonary arteries: Basis for combined Norwood stage I and II repair in hypoplastic left heart
5. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome
6. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome
7. Outcome while awaiting heart transplantation in children: A comparison of congenital heart disease and cardiomyopathy
8. New UNOS rules: Historical background and implications for transplantation management. United Network for Organ Sharing
9. 15 Years of pediatric heart transplantation at the University of Pittsburgh: Lessons learned and future prospects
10. Long-term survivors of pediatric heart transplantation: A multicenter report of sixty-eight children who have survived longer than five years
11. Emergency department presentation and management of pediatric heart transplant recipients
12. Somatic growth in infant heart transplant recipients
13. Mechanisms of bone loss after cardiac transplantation
14. Renal function after pediatric cardiac transplantation: The effect of early cyclosporine dosage
15. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study
16. Induction immunotherapy in pediatric heart transplant recipients: A multicenter study
17. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life
18. ABO-incompatible heart transplantation in infants
19. Differential development of type 1 and type 2 cytokines and beta-chemokines in the ontogeny of healthy newborns
20. T cell receptor repertoire diversity and clonal expansion in human neonates
21. Neonatal immunology
22. Evaluation of the age-dependent development of lymphocyte surface receptors in children
23. Neonatal dexamethasone treatment induces long-lasting changes in T-cell receptor beta repertoire in rats
24. Ontogeny of the responses of human peripheral blood T cells to glucocorticoids
25. Neonatal thymectomy: Does it affect immune function?
26. Anti-T-cell-antibody prophylaxis in children: Success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum
27. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus
28. Usefulness of tacrolimus versus cyclosporine after pediatric heart transplantation
29. Optimal dosing of intravenous tacrolimus following pediatric heart transplantation
30. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression
31. Experience of FK506 immune suppression in pediatric heart transplantation: A study of long-term adverse effects
32. Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients
33. Controversies in heart and lung transplantation immunosuppression: Tacrolimus versus cyclosporine
34. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression
35. The effect of immunosuppression on post-transplant lymphoproliferative disease in pediatric liver transplant patients
36. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients
37. Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy
38. Cyclosporine-based steroid-free therapy in pediatric heart transplantation: Long-term results
39. The Registry of the International Society of Heart Lung Transplantation: Third Official Pediatric Report-1999
40. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil
41. Orthotopic transplantation during early infancy as therapy for incurable congenital heart disease
42. Long-term follow-up of pediatric cardiac transplant recipients on a steroid-free regime: The role of endomyocardial biopsy
43. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression
44. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
45. Pediatric utilization of rapamycin for severe cardiac allograft rejection
46. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: A multi-institutional study
47. Surveillance endomyocardial biopsy in pediatric heart transplantation: Fashion or foible?
48. Non-invasive assessment of rejection in pediatric transplant patients: Serologic and echocardiographic prediction of biopsy-proven myocardial rejection
49. Serial echocardiographic evaluation of cardiac graft rejection after infant heart transplantation
50. Heart transplant rejection with hemodynamic compromise: A multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database
51. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation: Comparison with endomyocardial biopsy
52. An improved echocardiographic rejection-surveillance strategy following pediatric heart transplantation
53. Complications of endomyocardial biopsy in children
54. Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation
55. Endomyocardial biopsy in pediatric heart transplant recipients: A useful exercise? (analysis of 1,169 biopsies)
56. Non-invasive cardiac allograft monitoring: The graz experience
57. Noninvasive cardiac allograft monitoring
58. Pathologic markers of allograft arteriopathy: Insight into the pathophysiology of cardiac allograft chronic rejection
59. Immunosuppression for pediatric cardiac transplantation in the modern era
60. Infection after pediatric heart transplantation: Results of a multiinstitutional study
61. Post-transplantation lymphoproliferative disorders in pediatric thoracic organ recipients
62. Recommended immunization practices for pediatric renal transplant recipients
63. Transplantation tolerance induced by mixed chimerism